Status:
COMPLETED
Optimization of a New Adaptive Intervention to Increase COVID-19 Testing
Lead Sponsor:
University of Illinois at Urbana-Champaign
Collaborating Sponsors:
North Jersey Community Research Initiative
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
COVID-19 Testing
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable popul...
Detailed Description
This study will use the Multiphase Optimization Strategy (MOST) to optimize an adaptive intervention that successfully navigates COVID-19 medically or socially vulnerable people through a continuum of...
Eligibility Criteria
Inclusion
- over 18 years of age
- having high risk to contract COVID or develop related complications
- able to speak English
- able and willing to provide informed consent.
Exclusion
- under 18 years of age
- not at high risk to contract COVID or develop related complications
- unable to speak English
- unable and unwilling to provide informed consent
Key Trial Info
Start Date :
February 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2022
Estimated Enrollment :
668 Patients enrolled
Trial Details
Trial ID
NCT04757298
Start Date
February 12 2021
End Date
October 25 2022
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
North Jersey Community Research Initiative
Newark, New Jersey, United States, 07102